Tradestie Institutional Equity Comparison Engine

STTK vs SGMO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

STTK Overall Edge

STTK Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shattuck Labs, Inc. Common Stock (STTK) driven by superior Growth & Margin, Momentum & Technical while SGMO counters with relative strength in Valuation, Options & Structure. Fundamentally, STTK trades at N/M Forward P/E with 0.0% operating margin (-66.6% YoY revenue) versus SGMO at 0.4x Forward P/E and -175.5% operating margin (+88.4% YoY). In options structure, STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against SGMO sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SGMO
STTK N/M vs SGMO 0.4x Fwd P/E
Growth & Margin Winner STTK
Op Margin 0.0% vs -175.5% ยท YoY -66.6% vs +88.4%
Momentum & Technical Winner STTK
1Y +154.9% vs -76.0% ยท 52W Pos 45% vs 9%
Options & Structure Winner SGMO
BREAKDOWN (10th %ile IV) vs UNCLASSIFIED (71st %ile IV)
STTK NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.69
+0.86% 1D
Market Cap $474.6M
1M Return -13.47%
1Y Return +154.89%
Forward P/E N/M
Unified AI Score
51.1 / 100 HOLD
Tech 48.0 Fund 58.0 Flow 63.0 Mom 60.0
SGMO NASDAQ
Sangamo Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.18
+31.56% 1D
Market Cap $55.9M
1M Return -40.82%
1Y Return -76.04%
Forward P/E 0.4x
Unified AI Score
52.0 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STTK +154.89% SGMO -76.04% Spread: +336.55 pp (STTK Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period STTK Revenue SGMO Revenue STTK Op. Margin SGMO Op. Margin Margin Edge
Q1 '25 N/A $30M N/A -460.3% SGMO
Q2 '25 N/A $70M N/A -97.5% SGMO
Q3 '25 $0M $0M -1071.6% -6119.3% STTK
Q4 '25 N/A $60M N/A -175.5% SGMO
Q1 '26 N/A $10M N/A -2215.4% SGMO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STTK (5) vs SGMO (4)
Institutional Metric STTK SGMO Criterion Row Winner
Market Capitalization Scale $474.6M $55.9M Larger Scale STTK
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Forward P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Revenue Growth (YoY) Growth -66.6% +88.4% Higher Growth SGMO
Operating Margin (TTM) Profitability 0.0% -175.5% Higher Margin STTK
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -47.2% -2891.8% Higher ROE STTK
52-Week Range Position Momentum 45% ($2โ€“$8) 9% ($0โ€“$1) Stronger Trend STTK
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 78% Vol 1.49ฮฒ ยท 206% Vol Lower Realized Risk STTK
Unified Institutional Score Composite Signal 51.1 / 100 (HOLD) 52.0 / 100 (HOLD) Higher Composite SGMO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STTK vs SGMO Buy Guide
STTK BREAKDOWN
58d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live STTK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGMO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 71st %ile
IV Regime Elevated (60thโ€“80th %ile)
Live SGMO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STTK nor SGMO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.